ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 770

Detection of Proteins in Lung Tissues of Patients with Systemic Sclerosis Using Tissue Microarrays

Frank Schneider1 and Carol A. Feghali-Bostwick2, 1Pathology, University of Pittsburgh, Pittsburghh, PA, 2Medicine, Medical University of South Carolina, Charleston, SC

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: fibrosis, Lung, scleroderma and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Research on systemic sclerosis (SSc)-associated interstitial lung disease (ILD) has been hindered by the paucity of lung tissues, as SSc patients with lung involvement are not routinely biopsied. To gain further insights into the pathogenesis of lung fibrosis in SSc, we used lung tissue microarrays (TMAs) for the detection of 4 proteins of interest in SSc-associated ILD and idiopathic pulmonary fibrosis (IPF).

Methods: Lung tissues were obtained from the explanted lungs of patients undergoing lung transplantation. Normal lung tissues were obtained from controls. H&E sections were used for the selection of suitable regions. These regions were used for obtaining 1 mm cores. A TMA was constructed containing 117 cores from patients with SSc-associated ILD, IPF, and normal controls. Sections from the TMA block were used for detection of TTF-1, thrombomodulin, laminin, and Smad4 using immunohistochemistry (IHC). Distribution and levels of expression were qualitatively assessed using light microscopy.

Results: TTF-1, thrombomodulin, laminin, and Smad4 were detected in all cores on the TMA slide. The distribution of the proteins differed in normal lungs compared to fibrotic lungs since the two subepithelial layers in normal lungs are closely apposed in the absence of fibrosis. We observed subtle differences in distribution and levels of protein expression between SSc and IPF. TTF-1 expression appeared reduced in areas of fibrosis and inflammation in both diseases. Thrombomodulin staining of airway basal cells was weaker and patchier in SSc than IPF. Laminin expression was reduced in areas of fibrosis in both SSc and IPF, but IPF lungs showed stronger laminin staining around vessels compared to SSc lungs. Nuclear Smad4 expression was more prominent and more widespread in perivascular smooth muscle cells of SSc than IPF lungs.

Conclusion: Lung TMAs are useful to simultaneously compare localization and expression levels of proteins in lung tissues from multiple patients and controls. Our initial IHC findings suggest that differences exist in the distribution and levels of TTF-1, thrombomodulin, laminin, and Smad4, and such differences can be identified using TMAs.


Disclosure:

F. Schneider,
None;

C. A. Feghali-Bostwick,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/detection-of-proteins-in-lung-tissues-of-patients-with-systemic-sclerosis-using-tissue-microarrays/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology